Antibiotic-resistant pathogens present an increasing global health concern. Our group is investigating synthetic biology-based strategies for suppression of resistance in environmental bacterial populations. This approach involves the delivery of engineered genetic elements to target populations. We are developing models of the dynamics of this system, at both the genetic and population level, to be used in model-based design of treatment strategies. Analysis of proof-of-principle scenarios and accompanying experimental results will be presented.